Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia.

Roloff, Gregory W; Lai, Catherine; Hourigan, Christopher S; Dillon, Laura W

Roloff, Gregory W; Lai, Catherine; Hourigan, Christopher S; Dillon, Laura W.

Afiliação

Roloff GW; Myeloid Malignances Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. gregory.roloff@gmail.com.
Lai C; Myeloid Malignances Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. catherine.lai@nih.gov.
Hourigan CS; Myeloid Malignances Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. hourigan@nih.gov.
Dillon LW; Myeloid Malignances Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. laura.dillon2@nih.gov.

J Clin Med ; 6(9)2017 Sep 19.

Article em En | MEDLINE | ID: mdl-28925935

Palavras-chave

acute myeloid leukemia; droplet digital polymerase chain reaction; error-corrected sequencing; imaging; minimal residual disease; next-generation sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: J Clin Med Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google